Finward Bancorp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
Finward Bancorp's BMY Position: Q2 2026 in Review
Finward Bancorp held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,695 shares worth $213K. The position accounts for 0.16% of the portfolio, ranked #103.
Finward Bancorp first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $225K in Q1 2025. 566 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Finward Bancorp held 3,695 shares of Bristol-Myers Squibb worth $213K as of Q2 2026.
- Finward Bancorp left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.16% of Finward Bancorp's portfolio in Q2 2026, its #103 holding.
- Finward Bancorp first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
- Finward Bancorp's Bristol-Myers Squibb position peaked at $225K in Q1 2025.
- 566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.